DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
BRICICLIB SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BRICICLIB SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
7C9N0VM8NR
Molecule Type:
Small molecule
Molecular Formula:
C19H21Na2O10PS
Molecular Weight:
518.39
AlogP:
2.78
PSA:
137.82
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TALADEGIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis
Smoothened homolog antagonist
TALADEGIB
×
Maximum Phase:
1
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RECILISIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase class I inhibitor
RECILISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
F5V4K11SYV
Molecule Type:
Small molecule
Molecular Formula:
C16H13ClO4S
Molecular Weight:
336.8
AlogP:
3.62
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
LEVOSULPIRIDE
1
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Psychomotor Agitation; Psychotic Disorders
Dopamine D2 receptor antagonist
LEVOSULPIRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY-3200882
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3200882
×
Maximum Phase:
1
First Approval:
None
UNII:
19HY34R6UN
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.67
PSA:
94.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ZD-4190
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor 2 inhibitor
ZD-4190
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H17BrClFN6O2
Molecular Weight:
495.74
AlogP:
3.95
PSA:
86.98
HBD:
1.0
HBA:
#RotB:
7.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BMS-903452
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus
Unknown
BMS-903452
×
Maximum Phase:
1
First Approval:
None
UNII:
49731B9ULN
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2FN4O4S
Molecular Weight:
513.38
AlogP:
3.52
PSA:
94.39
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CONTELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
ALK tyrosine kinase receptor inhibitor
CONTELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
URX2UMQ8XV
Molecule Type:
Small molecule
Molecular Formula:
C32H45N9O3S
Molecular Weight:
635.84
AlogP:
3.84
PSA:
126.99
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GCC-4401C
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GCC-4401C
×
Maximum Phase:
1
First Approval:
None
UNII:
I636054KKA
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClN5O3S
Molecular Weight:
419.89
AlogP:
2.51
PSA:
86.27
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BMS-387032
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms
Cyclin-dependent kinase 2 inhibitor
BMS-387032
×
Maximum Phase:
1
First Approval:
None
UNII:
9979I93686
Molecule Type:
Small molecule
Molecular Formula:
C17H24N4O2S2
Molecular Weight:
380.54
AlogP:
3.66
PSA:
80.05
HBD:
2.0
HBA:
#RotB:
5.0
Source:
N6022
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Alcohol dehydrogenase class III inhibitor
N6022
×
Maximum Phase:
1
First Approval:
None
UNII:
80LIU5P95D
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4O3
Molecular Weight:
414.47
AlogP:
3.75
PSA:
103.14
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
METHYL P-TOLUENESULFONYL-L-ARGININATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYL P-TOLUENESULFONYL-L-ARGININATE
×
Maximum Phase:
1
First Approval:
None
UNII:
1H7BKF44U1
Molecule Type:
Small molecule
Molecular Formula:
C14H22N4O4S
Molecular Weight:
342.42
AlogP:
-0.13
PSA:
136.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CYCLOHEXANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYCLOHEXANE
×
Maximum Phase:
1
First Approval:
None
UNII:
48K5MKG32S
Molecule Type:
Small molecule
Molecular Formula:
C6H12
Molecular Weight:
84.16
AlogP:
2.34
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROBENETINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROBENETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Q72DWI2G4C
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.91
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ASP-3026
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms
ALK tyrosine kinase receptor inhibitor
ASP-3026
×
Maximum Phase:
1
First Approval:
None
UNII:
HP4L6MXF10
Molecule Type:
Small molecule
Molecular Formula:
C29H40N8O3S
Molecular Weight:
580.76
AlogP:
3.77
PSA:
115.82
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LENRISPODUN
1
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Parkinson Disease; Schizophrenia
Unknown
LENRISPODUN
×
Maximum Phase:
1
First Approval:
None
UNII:
3GBO34D1BE
Molecule Type:
Small molecule
Molecular Formula:
C29H26FN7O
Molecular Weight:
507.57
AlogP:
5.06
PSA:
78.65
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PLX-51107
1
Small molecule
Investigational
Unknown
Unknown
Graft vs Host Disease
Unknown
PLX-51107
×
Maximum Phase:
1
First Approval:
None
UNII:
W758F1L9ND
Molecule Type:
Small molecule
Molecular Formula:
C26H22N4O3
Molecular Weight:
438.49
AlogP:
5.68
PSA:
94.04
HBD:
1.0
HBA:
#RotB:
5.0
Source:
D6-25-HYDROXYVITAMIN D3
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D6-25-HYDROXYVITAMIN D3
×
Maximum Phase:
1
First Approval:
None
UNII:
378HY809HV
Molecule Type:
Small molecule
Molecular Formula:
C27H44O2
Molecular Weight:
406.68
AlogP:
6.73
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
6.0
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TEMSAVIR
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TEMSAVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
4B6J53W8N3
Molecule Type:
Small molecule
Molecular Formula:
C24H23N7O4
Molecular Weight:
473.49
AlogP:
1.63
PSA:
126.31
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
73
74
75
76
77
78
79
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA